Saturday, January 31, 2026

Nikola Stock Bounces Back with 10% Surge After Previous Day’s 9% Drop

Nikola's stock surged over 10% after a sharp decline, driven by bargain hunters amid ongoing bankruptcy speculation.

Samsung Biologics Earns EcoVadis Platinum: What Joining the Top 1% Signals for Global Pharma Supply Chains

Samsung Biologics achieves Platinum rating from EcoVadis, recognizing its top-tier ESG performance in sustainability and corporate responsibility.

North Korea Marks Korean War Anniversary With Renewed Calls for Self-Reliance

On the 75th anniversary of the Korean War, DPRK emphasizes self-reliance and criticizes U.S. actions as undermining peace and sovereignty.

Tag: GLP-1 treatments

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Top News

- Our Sponsors Ad -

Follow us